Figure 4 from Composition and Functional State of T and NK Cells in the Extramedullary Myeloma Tumor Microenvironment

Read full text
Authors: Anjana Anilkumar Sithara, Veronika Kapustová, David Žihala, Ondrej Venglár, Daniel Bilek, Moutaz Helal, Mara John, Eva Radova, Lucie Broskevičová, Jan Vrána, Gabriela Havlova, Ludmila Muroňová
+20 more Tereza Popková, Jana Mihályová, Hana Plonková, Serafim Nenarokov, Kamlesh Kumar Bisht, Hongfang Wang, Helgi J. Van de Velde, Sandra Charvátová, Ivo Demel, Michal Kaščák, Milan Navratil, Martin Havel, Juli Bago, Michal Šimíček, Angela Riedel, Leo Rasche, Tereza Ševčíková, Ola Landgren, Roman Hajek, Tomas Jelínek
Cited by: 0

Abstract

EMM tumors display high proportions of CD16− NK cells. A, scRNA-seq data. UMAP showing clusters in the NK cell compartment, a total of 1,679 cells distinguishable by the color-coded legend (left). UMAP of NK subclusters separated for each sample type displaying cells in EMM, EMM_BM, and RRMM_BM, with the colors representing the same cell type as in the global UMAP of the NK compartment (right). UMAPs showing the expression of CD16 and CD56 in the NK cell compartment (bottom). B, Stacked bar plot showing patient-wise contribution to scRNA-seq NK cell clusters. The proportions sum to 100% across EMM, EMM_BM, and RRMM samples. Box plot indicating the proportion of NK cell subclusters in (C) scRNA-seq and (D) FCM cohorts, color-coded by sample type. E, Box plot indicating the proportion of cells in different cell-cycle phases in CD16+ and CD16− NK cell clusters across sample types. F, Dot plot showing the expression of a curated list of genes in NK subclusters across different sample types. Box plots display the median (center line), the 25th and 75th percentiles (box limits), and whiskers extending to the most extreme data points within 1.5× the IQR. Statistical comparisons were performed using the Wilcoxon rank-sum test with Benjamini–Hochberg correction for multiple testing. n.s., not significant; **, P < 0.05.

Fields of Study & Subjects

Multiple Myeloma Research and Treatments Immune Cell Function and Interaction Lymphoma Diagnosis and Treatment

Publication details

Publication date
4 March 2026
Language
EN